Shigeru Ohno Selected Research

Shigeru Ohno Research Topics

Disease

9	Rheumatoid Arthritis 10/2020 - 01/2006
4	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2022 - 01/2014
3	Fever (Fevers) 02/2007 - 03/2002
2	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 01/2016
2	Ulcer 10/2016 - 06/2010
2	Arthritis (Polyarthritis) 02/2007 - 04/2003
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2022
1	Necrosis 01/2022
1	Bone Fractures (Bone Fracture) 01/2022
1	Mixed Connective Tissue Disease (MCTD) 01/2022
1	Hypertension (High Blood Pressure) 06/2021
1	Dermatomyositis (Dermatopolymyositis) 09/2020
1	Interstitial Lung Diseases (Interstitial Lung Disease) 09/2020
1	Infections 09/2020
1	Neoplasms (Cancer) 01/2016
1	Hepatitis 06/2012
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 09/2011
1	Hemorrhage 07/2011
1	Uveitis 02/2011
1	Behcet Syndrome (Behcet's Syndrome) 02/2011
1	Hypersensitivity (Allergy) 02/2011
1	Systemic Scleroderma (Systemic Sclerosis) 06/2010
1	Tuberculosis (Tuberculoses) 03/2009
1	Erythema 03/2009
1	Inflammation (Inflammations) 02/2007
1	Oral Ulcer (Mouth Ulcer) 02/2007
1	Liver Diseases (Liver Disease) 01/2005
1	Rheumatic Diseases (Rheumatism) 01/2005
1	Adult-Onset Still's Disease 01/2005
1	Hyperferritinemia 01/2005
1	Adenocarcinoma of Lung 01/2005
1	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 01/2005
1	Myalgia 10/2003
1	Cough 10/2003
1	Scleritis (Episcleritis) 10/2003
1	Temporomandibular ankylosis 04/2003
1	Lung Neoplasms (Lung Cancer) 02/2003
1	Disease Progression 02/2003
1	Osteoarthritis 01/2003
1	Bone Resorption 01/2003
1	Eosinophilic Fasciitis 06/2002
1	Exanthema (Rash) 03/2002

Drug/Important Bio-Agent (IBA)

4	Prednisolone (Predate)FDA LinkGeneric 06/2021 - 03/2002
3	Methotrexate (Mexate)FDA LinkGeneric 10/2020 - 04/2007
3	Antirheumatic Agents (DMARD)IBA 11/2019 - 01/2006
2	Infliximab (Remicade)FDA Link 02/2011 - 02/2007
1	AntibodiesIBA 01/2022
1	Vitamin D FDA LinkGeneric 01/2022
1	Denosumab FDA Link 01/2022
1	HLA-DRB1 Chains (HLA DRB1)IBA 01/2022
1	cyclo(Arg-Pro) (CI 4)IBA 01/2022
1	RibonucleoproteinsIBA 01/2022
1	HLA-DRB1*04:01 antigenIBA 01/2022
1	LDL CholesterolIBA 06/2021
1	Triglycerides (Triacylglycerol)IBA 06/2021
1	Biomarkers (Surrogate Marker)IBA 09/2020
1	Biological ProductsIBA 11/2019
1	HLA-B51 AntigenIBA 10/2016
1	HLA-G Antigens (HLA G)IBA 01/2016
1	Protein Isoforms (Isoforms)IBA 01/2016
1	3' Untranslated Regions (3' UTR)IBA 01/2016
1	Peptides (Polypeptides)IBA 01/2015
1	Interferon Regulatory Factor-2 (Interferon Regulatory Factor 2)IBA 01/2014
1	HLA-DR6 Antigen (HLA DR6 Antigen)IBA 01/2014
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2014
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 06/2012
1	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 09/2011
1	Warfarin (Coumadin)FDA LinkGeneric 07/2011
1	Adalimumab (Humira)FDA Link 02/2011
1	EnzymesIBA 03/2009
1	AntigensIBA 03/2009
1	Tuberculin (PPD)IBA 03/2009
1	Adrenal Cortex Hormones (Corticosteroids)IBA 03/2009
1	Proteins (Proteins, Gene)FDA Link 03/2009
1	Interferon-gamma (Interferon, gamma)IBA 03/2009
1	FluorineIBA 01/2009
1	Glucose (Dextrose)FDA LinkGeneric 01/2009
1	Tumor Necrosis Factor InhibitorsIBA 02/2007
1	Prednisone (Sone)FDA LinkGeneric 02/2007
1	Monoclonal AntibodiesIBA 02/2007
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2007
1	Heme (Haem)IBA 01/2005
1	Ferritins (Ferritin)IBA 01/2005
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2005
1	Transforming Growth Factor beta (TGF-beta)IBA 01/2005
1	HPS 10IBA 01/2005
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 10/2003
1	Methylprednisolone FDA LinkGeneric 10/2003
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2003
1	Matrilin ProteinsIBA 04/2003
1	pyridinolineIBA 01/2003
1	deoxypyridinolineIBA 01/2003
1	CytokinesIBA 06/2002
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 03/2002

Therapy/Procedure

4	Therapeutics 06/2012 - 02/2003
1	Aftercare (After-Treatment) 06/2010
1	Autologous Transplantation 06/2010
1	Biological Therapy 03/2009
1	Blood Transfusion (Blood Transfusions) 01/2005